Ian McDonald
Chief Executive Officer, Director
Our Approach
We harness our team’s decades of experience in the biology of the serotonergic system to understand the effect specific receptors have on our body. From there, we create new and modify existing molecules in order to reduce unwanted side effects and accentuate positive therapeutic properties.
This new generation of highly targeted serotonergic drugs will be able to reach specific patient populations that the compounds of today cannot.
Our Science
Our Team
Chief Executive Officer, Director
Director, Chief Science Officer
Chief Medical Officer
Chief Financial Officer
Vice President of Pharmacology
Senior Advisor
Senior Advisor
Advisor
Toxicology Advisor
Senior Advisor
Advisor
Senior Advisor
Scientific Officer
"*" indicates required fields